Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA003868 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA003868, RRID:AB_1079290
- Product name
- Anti-MIF
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human MIF, Gene description: macrophage migration inhibitory factor (glycosylation-inhibiting factor), Alternative Gene Names: GIF, GLIF, Validated applications: IHC, WB, ICC, Uniprot ID: P14174, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
TRNT-1 Deficiency Is Associated with Loss of tRNA Integrity and Imbalance of Distinct Proteins
Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
Alterations in neuronal metabolism contribute to the pathogenesis of prion disease
Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
Parol‐Kulczyk M, Durślewicz J, Blonkowska L, Wujec R, Gzil A, Piątkowska D, Ligmanowska J, Grzanka D
The Journal of Pathology: Clinical Research 2024;10(2)
The Journal of Pathology: Clinical Research 2024;10(2)
TRNT-1 Deficiency Is Associated with Loss of tRNA Integrity and Imbalance of Distinct Proteins
Fatica T, Naas T, Liwak U, Slaa H, Souaid M, Frangione B, Kattini R, Gaudreau-Lapierre A, Trinkle-Mulcahy L, Chakraborty P, Holcik M
Genes 2023;14(5):1043
Genes 2023;14(5):1043
Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study
Batra S, Parol-Kulczyk M, Gzil A, Maciejewska J, Bodnar M, Grzanka D
PLOS ONE 2021;16(6):e0253112
PLOS ONE 2021;16(6):e0253112
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
Klemke L, De Oliveira T, Witt D, Winkler N, Bohnenberger H, Bucala R, Conradi L, Schulz-Heddergott R
Cell Death & Disease 2021;12(2)
Cell Death & Disease 2021;12(2)
Alterations in neuronal metabolism contribute to the pathogenesis of prion disease
Bourgognon J, Spiers J, Scheiblich H, Antonov A, Bradley S, Tobin A, Steinert J
Cell Death & Differentiation 2018;25(8):1408-1425
Cell Death & Differentiation 2018;25(8):1408-1425
Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.
Põlajeva J, Bergström T, Edqvist PH, Lundequist A, Sjösten A, Nilsson G, Smits A, Bergqvist M, Pontén F, Westermark B, Pejler G, Forsberg Nilsson K, Tchougounova E
Molecular oncology 2014 Feb;8(1):50-8
Molecular oncology 2014 Feb;8(1):50-8
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
Ma Y, Visser L, Roelofsen H, de Vries M, Diepstra A, van Imhoff G, van der Wal T, Luinge M, Alvarez-Llamas G, Vos H, Poppema S, Vonk R, van den Berg A
Blood 2008;111(4):2339-2346
Blood 2008;111(4):2339-2346
No comments: Submit comment
No validations: Submit validation data